Insights

Innovative Therapeutics The Whiteoak Group specializes in nucleic acid therapeutics utilizing cutting-edge QTsome technology, positioning it as a leader in advanced biotech solutions ideally suited for pharmaceutical companies seeking novel treatment modalities.

Market Growth Opportunity With projected revenue between 250 million and 500 million dollars, WGI presents a significant opportunity for collaboration with healthcare firms that are investing heavily in targeted drug delivery and personalized medicine.

Technology Integration The company's use of cloud and web technologies like Google Cloud, WordPress, and PHP indicates a scalable digital infrastructure, making it easier to support large-scale partnerships and client engagement in the biotech space.

Focus on Complex Diseases WGI’s expertise in overcoming delivery challenges in complex diseases such as oncology makes it a strategic partner for pharmaceutical and biotech firms aiming to develop innovative oncology treatments.

Growth & Collaboration Given its niche focus on nucleic acid therapeutics and scalable technology platforms, WGI is a promising prospect for companies looking to expand their R&D collaborations or invest in next-generation biomedical solutions.

The Whiteoak Group, Inc. Tech Stack

The Whiteoak Group, Inc. uses 8 technology products and services including Open Graph, Wix, WordPress, and more. Explore The Whiteoak Group, Inc.'s tech stack below.

Open Graph

Content Management System

Wix

Content Management System

WordPress

Content Management System

Sirvoy

Hotel Management

Google Cloud

Infrastructure As A Service

Priority Hints

Performance

WordPress.com

Platform As A Service

PHP

Programming Languages

The Whiteoak Group, Inc. Email Formats	Example	Percentage
First.Last@thewogroup.com	John.Doe@thewogroup.com	100%

The Whiteoak Group, Inc. Email Formats

Example

Percentage

First.Last@thewogroup.com

John.Doe@thewogroup.com

100%

Frequently Asked Questions

Where is The Whiteoak Group, Inc.'s headquarters located?

The Whiteoak Group, Inc.'s main headquarters is located at 1629 k Street Northwest Washington, District of Columbia 20006 United States. The company has employees across 2 continents, including North AmericaAsia.

What is The Whiteoak Group, Inc.'s official website and social media links?

The Whiteoak Group, Inc.'s official website is thewogroupinc.com and has social profiles on LinkedIn.

What is The Whiteoak Group, Inc.'s SIC code NAICS code?

The Whiteoak Group, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does The Whiteoak Group, Inc. have currently?

As of March 2026, The Whiteoak Group, Inc. has approximately 14 employees across 2 continents, including North AmericaAsia. Key team members include Chief Executive Officer: A. Y. M.Chief Medical Officer: A. M.Founder: B. Z.. Explore The Whiteoak Group, Inc.'s employee directory with LeadIQ.

What industry does The Whiteoak Group, Inc. belong to?

The Whiteoak Group, Inc. operates in the Biotechnology Research industry.

What technology does The Whiteoak Group, Inc. use?

The Whiteoak Group, Inc.'s tech stack includes Open GraphWixWordPressSirvoyGoogle CloudPriority HintsWordPress.comPHP.

What is The Whiteoak Group, Inc.'s email format?

The Whiteoak Group, Inc.'s email format typically follows the pattern of First.Last@thewogroup.com. Find more The Whiteoak Group, Inc. email formats with LeadIQ.

When was The Whiteoak Group, Inc. founded?

The Whiteoak Group, Inc. was founded in 2014.

The Whiteoak Group, Inc.

Q: How many employees does The Whiteoak Group, Inc. have currently?

The Whiteoak Group, Inc. has approximately 14 employees.

Q: What technology does The Whiteoak Group, Inc. use?

The Whiteoak Group, Inc.'s tech stack includes React, WordPress.com, Wix eCommerce, Priority Hints, Webpack.

Biotechnology ResearchDistrict of Columbia, United States11-50 Employees

Breakthrough Nucleic Acid Therapeutics by QTsomeTM Technology. 

Advances in medical technology and our understanding of biology have paved the way for the treatment diseases once thought incurable. Delivery of drug to the correct site of therapeutic action while minimizing off-target exposure is paramount to achieving safe and effective therapy. WGI overcomes delivery challenges in complex diseases including oncology through strategic application of nanotechnology.

Insights

Similar companies to The Whiteoak Group, Inc.

Cognizant

Tata Consultancy Services

Infosys

Accenture

Capgemini

Wipro

KPMG

Deloitte Consulting